Latest HBV Stories
Panel calls for a conservative approach until more clinical data and therapeutic options are available DOYLESTOWN, Pa., Oct.
GERMANTOWN, Maryland and DES PLAINES, Illinois, October 12, 2010 /PRNewswire-FirstCall/ -- QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Abbott (ABT: NYSE) today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed. Under the terms of the agreements, QIAGEN will receive kits for a PCR-based molecular assay...
PLEASANTON, Calif., Sept. 22 /PRNewswire-FirstCall/ -- Roche Molecular Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the COBASÂ® AmpliPrep / COBASÂ® TaqManÂ® HBV Test v2.0 for use in the United States.
WASHINGTON, DOYLESTOWN, Penn., and SAN FRANCISCO, Sept. 14 /PRNewswire/ -- The U.S.
DES PLAINES, Ill., Sept. 1 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) announced today it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient's blood.
Hepatitis B virus (HBV) and hepatitis C virus (HCV) can be transmitted during intravenous (IV) administration of anesthesia.
A University of Rochester study helps to explain why men get liver cancer more often than women and opens the door for a new treatment pathway, by showing a direct link between the androgen receptor, which is more active in men, and the hepatitis B virus as it relates to the deadly cancer.
Risk of non-Hodgkin lymphoma and cholangiocarcinoma in Taiwanese parous women with chronic hepatitis B virus infection.
Institute of Medicine makes recommendations to prevent HBV and HCV infections.
- A transitional zone between two communities containing the characteristic species of each.